Non-germline genetically engineered mouse models for translational cancer research

Joerg Heyer1, Lawrence N Kwong, Scott W Lowe

  • 1AVEO Pharmaceuticals, 75 Sidney Street, 4th floor, Cambridge, MA 02139, USA.

Summary

New non-germline genetically engineered mouse models (nGEMMs) offer faster, more flexible, and cost-effective cancer research. These models improve preclinical therapeutic testing and accelerate cancer insights.